Katie Woods, MBBS, MRCP, MD - Pediatric Endocrinology | 503-418-5710
Dr. Woods’ research interests lie in the area of growth, particularly the physiology and the molecular pathology of the growth hormone (GH)- insulin-like growth factor -I (IGF-I) axis. Dr Woods has characterized several pathologic mutations in the genes involved the regulation of the GH-IGF axis, and described phenotype-genotype associations in GH receptor deficiency. Dr. Woods was instrumental in the identification and characterization of the first human case of a mutation in the IGF-1 gene in man, which provided important insights into IGF-I functioning in the human in both pre-and postnatal life. She is currently pursuing genetic studies in subjects with IGF deficient short stature, and is involved in clinical trials of recombinant IGF-I therapy in human subjects. She is affiliated with Oregon Health and Science University (OHSU)
Dr. John Chunn
Board Certified Pediatrician
What do you think?
COPA wants to exceed your expectations as the families and caregivers of the children we serve. We appreciate any feedback you can provide on how we're doing and how we can improve.